AVITA Medical, Inc. Quarterly Depreciation in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
AVITA Medical, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q2 2024.
  • AVITA Medical, Inc. Depreciation for the quarter ending June 30, 2024 was $187K, a 36.5% increase year-over-year.
  • AVITA Medical, Inc. Depreciation for the twelve months ending June 30, 2024 was $707K, a 37.3% increase year-over-year.
  • AVITA Medical, Inc. annual Depreciation for 2023 was $597K, a 17.1% increase from 2022.
  • AVITA Medical, Inc. annual Depreciation for 2022 was $510K, a 15.8% decline from 2021.
  • AVITA Medical, Inc. annual Depreciation for 2021 was $606K, a 75.1% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $707K $187K +$50K +36.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $657K $186K +$60K +47.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $597K $178K +$56K +45.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $541K $156K +$26K +20% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $515K $137K +$8K +6.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $507K $126K -$3K -2.33% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $510K $122K Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $130K -$17K -11.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $129K -$16K -11% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $129K -$8K -5.84% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $564K $147K -$41K -21.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $605K $145K +$39K +36.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $566K $137K +$51K +59.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $515K $135K +$47K +53.4% Oct 1, 2020 Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $468K $188K +$122K +185% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $346K $106K Apr 1, 2020 Jun 30, 2020 10-KT 2022-02-28
Q1 2020 $86K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $88K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $66K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.